ESR1 and breast cancer: However, it is conceivable that epigenetic modifications are implicated in the E2-liganded ERα deleterious effect on CIITA pIV, as numerous epigenetic modifications have been described in breast cancer that include silencing of ERα in the MDA-MB-231 cell line and downregulation of tumor suppressor genes [69]–[73].